Prof. Xingang Li, Department of Pharmacy, Beijing Friendship Hospital, China
Prof. Xingang Li is the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, China, where he also serves as a Chief Pharmacist, Professor, and Ph.D. Supervisor. An expert in quantitative pharmacology and genetic pharmacology, Prof. Li has published over 50 articles in top-tier journals, with more than 1000 citations and an H-index of 20. He is an External Expert at the National Center for Drug Evaluation, a member of multiple prestigious pharmacological committees, and a reviewer for leading journals such as Biomaterials and Clin Transl Med. His research focuses on personalized medicine, drug delivery systems, and epigenetic influences on pharmacodynamics.
Profile:
Orcid Profile
🏥 Current Positions:
Prof. Li Xingang serves as the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, where he is also the Chief Pharmacist. As a Professor and Ph.D. Supervisor, he is instrumental in nurturing future generations of pharmacists and researchers. His leadership role involves overseeing advanced pharmacological practices, mentoring young scientists, and ensuring cutting-edge drug evaluation and management systems. With a strong emphasis on precision medicine, Prof. Li combines clinical expertise and research excellence to address pressing healthcare challenges.
📚 Academic Background:
Prof. Li has an extensive academic background, which underpins his outstanding contributions to quantitative pharmacology and genetic pharmacology. His role as an External Expert at the National Center for Drug Evaluation and Review Expert for the Beijing Science and Technology Plan Project showcases his authority in the field. His memberships in prestigious committees, such as the Quantitative Pharmacology Committee of the Chinese Pharmacological Society and the Epigenetics Committee, reflect his deep commitment to advancing pharmaceutical sciences.
🧪 Research Interests and Achievements:
Quantitative Pharmacology: Prof. Li has a keen interest in developing predictive models to optimize drug efficacy and safety, leveraging mathematical frameworks to personalize treatment.
Genetic Pharmacology: His research focuses on exploring genetic factors that influence drug metabolism and efficacy, aiming to enhance personalized medicine approaches.
Prof. Li has successfully led over ten major projects, including initiatives funded by the Ministry of Science and Technology, the National Natural Science Foundation, and the Beijing Science and Technology Plan. These projects address critical areas like drug delivery systems, personalized pharmacotherapy, and genetic determinants of drug response.
🖋️ Publication Achievements:
Prof. Li’s academic rigor is evident in his extensive publication record, with over 50 articles in Q1 journals such as Nano Letters, Acta Pharmacologica Sinica, and Phytomedicine. His works have been cited more than 1000 times, and he holds an impressive H-index of 20, reflecting his impact on the scientific community. His publications explore innovative drug delivery systems, genetic biomarkers, and clinical pharmacokinetics, contributing significantly to global pharmacological advancements.
🏆 Scholarships and Awards:
Prof. Li has received numerous accolades for his contributions:
- Servier Young Hospital Pharmacy Award, China Pharmaceutical Society
- Outstanding Pharmacist Award, Beijing Pharmaceutical Society
- Recognized for Outstanding Papers and groundbreaking research, reflecting his excellence in clinical pharmacy and translational research.
🧑🔬 Professional Associations and Editorial Roles:
Prof. Li is actively involved in professional organizations, including the Chinese Pharmacological Society and the China Pharmaceutical Education Association. He serves as an Editorial Board Member for journals such as China Hospital Pharmacy Evaluation and Analysis and Chinese Pharmacy, ensuring the dissemination of high-quality research.
As a Reviewer for prestigious journals like Biomaterials and Clin Transl Med, he evaluates cutting-edge studies in pharmacology, bioinformatics, and materials science, further contributing to his field’s knowledge base.
💻 Bioinformatics and Laboratory Experience:
Prof. Li integrates bioinformatics tools into his research to analyze complex datasets and identify genetic markers associated with drug response. His laboratory is equipped with advanced technologies for pharmacokinetic modeling, epigenetic profiling, and drug formulation analysis, enabling groundbreaking discoveries.
🎓 Training, Workshops, and Oral Presentations:
Prof. Li regularly participates in international conferences, presenting his research findings and engaging with global experts. His oral presentations at prestigious forums highlight advancements in therapeutic drug monitoring (TDM), anesthesiology pharmacy, and intravenous preparation management, solidifying his reputation as a thought leader.
✅ Tasks Completed as a Researcher:
Prof. Li has successfully completed tasks ranging from designing clinical trials to publishing high-impact research. His ability to translate laboratory findings into practical solutions for patient care exemplifies his commitment to improving healthcare outcomes.
🌟 Success Factors and Key Contributions:
Prof. Li’s success stems from his:
- Collaborative approach in multidisciplinary projects
- Innovative methodologies in drug evaluation and genetic research
- Dedication to mentoring young professionals and fostering academic growth
🔬 Ongoing Research Projects:
His current projects delve into:
- Advanced drug delivery systems to enhance treatment efficacy
- Epigenetic influences on pharmacodynamics
- Personalized medicine approaches using genetic profiling
🔍 Conclusion:
Prof. Li Xingang is a distinguished leader in the field of pharmacology, whose contributions span clinical excellence, innovative research, and impactful publications. His work in quantitative and genetic pharmacology, combined with his dedication to mentoring and professional engagement, sets him apart as a visionary in healthcare. His achievements and ongoing endeavors continue to shape the future of precision medicine and pharmacological sciences.
Top Notable Publications:
1. Immune-Related Colitis Induced by Camrelizumab: A Case Report
Authors: Xingang Li
Journal: Journal of Inflammation Research
Year: 2023
2. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients
Authors: Xingang Li
Journal: European Journal of Hospital Pharmacy: Science and Practice-
Year: 2023
3. Association of Alcohol Drinking and Helicobacter pylori Infection: A Meta-analysis
Authors: Xingang Li
Journal: Journal of Clinical Gastroenterology
Year: 2023
4. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients
Authors: Xingang Li
Journal: European Journal of Hospital Pharmacy: Science and Practice
Year: 2022
5. Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack
Authors: Xingang Li
Journal: Cerebrovascular Diseases (Basel, Switzerland)
Year: 2022
6. Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method
Authors: Xingang Li
Journal: Current Medical Science
Year: 2022
7. Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients
Authors: Xingang Li
Journal: Annals of Translational Medicine
Year: 2022
8. Development of a multivariable clinical prediction model for liposomal doxorubicin-induced cardiotoxicity in adult breast cancer patients: A retrospective multicenter study
Authors: Xingang Li
Journal: Annals of Translational Medicine
Year: 2022
9. Population pharmacokinetics of methotrexate in pediatric patients with acute lymphoblastic leukemia and malignant lymphoma
Authors: Xingang Li
Journal: Xenobiotica
Year: 2022
10. The clinical population pharmacokinetics, metabolomics, and therapeutic analysis of alkaloids from Alstonia scholaris leaves in acute bronchitis patients
Authors: Xingang Li
Journal: Phytomedicine
Year: 2022